Raymond James analyst John Ransom downgraded Accolade (ACCD) to Market Perform from Outperform without a price target after the company signed a definitive agreement to be acquired by Transcarent for $7.03 per share and a $621M equity value in an all-cash transaction. The firm thinks the deal makes “rational sense” given Accolade’s trading action and “depressed valuation” before the news.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue